Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Current Allergy and Asthma Reports
Published in: Current Allergy and Asthma Reports 11/2014

01-11-2014 | ALLERGIC SKIN DISEASES (L FONACIER, SECTION EDITOR)

Hand Dermatitis: an Allergist’s Nightmare

Authors: Lindsey Wold, Jennifer K. Chen, Heather P. Lampel

Published in: Current Allergy and Asthma Reports | Issue 11/2014

Login to get access

Abstract

Hand dermatitis is a common skin complaint. We use our hands to explore our environment; subsequently, our hands are in frequent contact with potential allergens and irritants. Patients with hand dermatitis may present to their allergist with this complaint. Approaching the diagnosis and treatment of hand dermatitis can be challenging, as both internal and external factors may contribute to the overall condition. Furthermore, the differential diagnosis of hand dermatitis is broad and the cause often multifactorial. Obtaining a thorough history and performing a focused examination may help the clinician differentiate between multiple causes of hand dermatitis. Numerous treatment options exist for hand dermatitis, and new potential treatments are in development as well. We aim to provide the allergist with a streamlined toolkit for help in the diagnosis and management of hand dermatitis.
Literature
1.
Thyssen JP, Johansen JD, Linneberg A, et al. The epidemiology of hand eczema in the general population—prevalence and main findings. Contact Dermatitis. 2010;62:75–87.PubMedCrossRef
2.••
Mortz CG, Bindslev-Jensen C, Andersen KE. Hand eczema in the TOACS cohort: prevalence, incidence and risk factors from adolescence to adulthood. Br J Dermatol. 2014 Mar 13. (epub). Longitudinal study evaluating the epidemiology of hand eczema from childhood through early adulthood.
3.
English J, Aldridge R, Gawkrodger DJ, et al. Consensus statement on the management of chronic hand eczema. Clin Exp Dermatol. 2009;34:761–9.PubMedCrossRef
4.
Turner S, Carder M, van Tongeren M, et al. The incidence of occupational skin diseases as reported to The Health and Occupation Reporting (THOR) network between 2002 and 2005. Br J Dermatol. 2007;157:713–22.PubMedCrossRef
5.
McCall BP, Horwitz IB, Feldman SR, et al. Incidence rates, costs, severity, and work-related factors of occupational dermatitis: a workers’ compensation analysis of Oregon, 1990-1997. Arch Dermatol. 2005;141:713–8.PubMedCrossRef
6.•
Ibler KS, Jemec GB, Flyvholm MA, et al. Hand eczema: prevalence and risk factors of hand eczema in a population of 2274 healthcare workers. Contact Dermatitis. 2012;67:200–7. Large study focusing on hand dermatitis prevalence and causation in health care workers.PubMedCrossRef
7.
Lampel HP, Patel N, Boyse K, et al. Prevalence of hand dermatitis in inpatient nurses at a United States hospital. Dermatitis. 2007;18:140–2.PubMedCrossRef
8.
Lantinga H, Nater JP, Coenraads PJ, et al. Prevalence incidence and course of eczema on the hands and forearms in a sample of general population. Contact Dermatitis. 1984;10:135–9.PubMedCrossRef
9.
Warshaw EM, Ahmed RL, Belsito DV, et al. Contact dermatitis of the hands: cross-sectional analyses of North American Contact Dermatitis Group data, 1994-2004. J Am Acad Dermatol. 2007;57:301–14.PubMedCrossRef
10.
Yoshihisa Y, Shimizu T. Metal allergy and systemic contact dermatitis: an overview. Dermatol Res Pract. 2012;2012:749561.PubMedCentralPubMed
11.
Kedrowski DA, Warshaw EM. Hand dermatitis: a review of clinical features, diagnosis and management. Dermatol Nurs. 2008;20:17–25.PubMed
12.
Simpson EL, Thompson MM, Hannifin JM. Prevalence and morphology of hand eczema in patients with atopic dermatitis. Dermatitis. 2006;17:123–7.PubMedCrossRef
13.
Roberson E, Bowcock A. Psoriasis genetics: breaking the barrier. Trends Genet. 2011;26:415–23.CrossRef
14.
15.
Ljubenovic MS, Ljubenovic DB, Binic II, et al. Acrokeratosis paraneoplastica (Bazex syndrome). Indian J Dermatol Venereol Leprol. 2009;75:329.PubMedCrossRef
16.
Yost JM, Boyd KP, Patel RR, et al. Necrolytic acral erythema. Dermatol Online J. 2013;19:20709.PubMed
17.
18.
McLean WH, Rugg EL, Lunny DP, et al. Keratin 16 and keratin 17 mutations cause pachyonychia congenita. Nat Genet. 1995;9:273–8.PubMedCrossRef
19.
Pohler E, Mamai O, Hirst J, et al. Haploinsufficiany for AAGAB causes clinically heterogeneous forms of punctate palmoplantar keratoderma. Nat Genet. 2012;44:10.PubMedCentralCrossRef
20.
Protonotarios N, Tsatsopoulou A. Naxos disease. Indian Pacing Electrophysiol. 2005;5:76–80.
21.
Heathcote K, Syrris N, Carter M, et al. A connexin 26 mutation causes a syndrome of sensorineural hearing loss and palmoplantar hyperkeratosis (MIM 148350). J Med Genet. 2000;37:50–1.PubMedCentralPubMedCrossRef
22.
23.
Samlaska CP, Sandberg GD, Maggio KL, et al. Generalized perforating granuloma annulare. J Am Acad Dermatol. 1992;27:319–22.PubMedCrossRef
24.
Mathias CGT. Contact dermatitis and worker’s compensation: criteria for establishing occupational causation and aggravation. J Am Acad Dermatol. 1989;20:842–8.PubMedCrossRef
25.
Alavi A, Skotnicki A, Sussman G, et al. Diagnosis and treatment of hand dermatitis. Adv Skin Wound Care: J Prev Heal. 2012;25:371–80.CrossRef
26.
McMullen E, Gawkrodger DJ. Physical friction is under-recognized as an irritant that can cause or contribute to contact dermatitis. Br J Dermatol. 2006;154:154–6.PubMedCrossRef
27.
Kwon S, Campbell LS, Zirwas MJ. Role of protective gloves in the causation and treatment of occupational irritant contact dermatitis. J Am Acad Dermatol. 2006;55:891–6.PubMedCrossRef
28.
Wassenberg S, Fischer-Kahle V, Herborn G, et al. A method to score radiographic change in psoriatic arthritis. J Rheumatol. 2001;60:156–66.
29.
Militello G, Woo DK, Kantor J, et al. Utility of the TRUE test in the private practice setting. Dermatitis. 2006;17:77–84.PubMed
30.
Patel D, Belsito DV. The detection of clinically relevant contact allergens with a standard screening tray of 28 allergens. Contact Dermatitis. 2012;66:154–8.PubMedCrossRef
31.
Velen NK, Olholm Larsen P, Thestrup-Pedersen K, et al. Long-term, intermittent treatment of chronic hand eczema with mometasone furoate. J Dermatol. 1999;140:882–6.CrossRef
32.
Möller H, Svartholm H, Dahl G. Intermittent maintenance therapy in chronic hand eczema with clobetasol propionate and flupredniden acetate. Curr Med Res Opin. 1983;8:640–4.PubMedCrossRef
33.
Schliemann S, Kelterer D, Bauer A, et al. Tacrolimus ointment in the treatment of occupationally induced chronic hand dermatitis. Contact Dermatitis. 2008;58:299–306.PubMedCrossRef
34.
Katsarou A, Makris M, Papagiannaki K, et al. Tacrolimus 0.1 % vs mometasone furoate topical treatment in allergic contact hand eczema: a prospective randomized clinical study. Eur J Dermatol. 2012;22:192–6.
35.
Segaert S, Ropke M. The biological rationale for use of vitamin d analogs in combination with corticosteroids for the topical treatment of plaque psoriasis. J Drugs Dermatol. 2013;12e129-137.
36.
Egawa K. Topical vitamin D3 derivatives in treating hyperkeratotic palmoplantar eczema: a report of five patients. J Dermatol. 2005;32:381–6.PubMedCrossRef
37.
Del Rosso JQ, Bhambri S, Michaels B. An aluminum magnesium hydroxide stearate-based skin barrier protection cream used for the management of eczematous dermatitis: a summary of completed studies. J Clin Aesthet Dermatol. 2008;1:18–21.PubMedCentralPubMed
38.
Del Rosso JQ, Levin J. The clinical relevance of maintaining the functional integrity of the stratum corneum in both healthy and disease-affected skin. J Clin Aesthet Dermatol. 2011;4:22–42.PubMedCentralPubMed
39.
Wolff K, Johnson RA, Suurmond D, et al. Fitzpatrick’s color atlas and synopsis of clinical dermatology. 6th ed. New York: McGraw-Hill; 2009. p. 30.
40.
41.
Mittal A, Khare AK, Gupta L, et al. Use of methotrexate in recalcitrant eczema. Indian J Dermatol. 2011;56:224.CrossRef
42.
Egan CA, Rallis TM, Meadows KP, et al. Low-dose oral methotrexate treatment for recalcitrant palmoplantar pompholyx. J Am Acad Dermatol. 1999;40:612–4.PubMedCrossRef
43.
Grandlund H, Erkko P, Eriksson E, et al. Comparison of cyclosporine and topical betamethasone-17,21-dipropionate in the treatment of severe chronic hand eczema. Acta Derm Venereol. 1996;76:371–6.
44.
Pang ML, Murase JE, Koo J. An updated review of acitretin—a systemic retinoid for the treatment of psoriasis. Expert Opin Drug Metab Toxicol. 2008;4:953–64.PubMedCrossRef
45.
Thestrup-Pedersen K, Andersen KE, Menne T, et al. Treatment of hyperkeratotic dermatitis of the palms (eczema keratoticum) with oral acitretin. A single-blind placebo-controlled study. Acta Derm Venereol. 2001;81:353–5.PubMedCrossRef
46.
Agarwal US, Besarwal RK. Topical clobetasol propionate 0.05 % cream alone and in combination with azathioprine in patients with chronic hand eczema: an observer blinded randomized comparative trial. Indian J Dermatol Venereol Leprol. 2013;79:101–3.
47.
48.
Denby K, Beck L. Update on systemic therapies for atopic dermatitis. Curr Opin Allergy Clin Immunol. 2012;12:421–6.PubMedCrossRef
49.
Schalock PC, Zug KA, Carter JC, et al. Efficacy and patient perception of grenz ray therapy in the treatment of dermatoses refractory to other medical therapy. Dermatitis. 2008;19:90–4.PubMed
50.
Abramovits W, Granowski P. Innovative management of severe hand dermatitis. Dermatol Clin. 2010;28:453–65.PubMedCrossRef
51.
Behrens S, von Kobyletzki G, Gruss C, et al. PUVA-bath photochemotherapy (PUVA-soak therapy) of recalcitrant dermatoses of the palms and soles. Photodermatol Photoimmunol Photomed. 1999;15:47–51.PubMedCrossRef
52.
Rosén K, Mobacken H, Swanbeck G. Chronic eczematous dermatitis of the hands: a comparison of PUVA and UVB treatment. Acta Derm Venereol. 1987;67:48–54.PubMed
53.
Ghasri P, Scheinfeld N. Update on the use of alitretinoin in treating chronic hand eczema. Clin Cosmet Investig Dermatol. 2010;3:59–65.PubMedCentralPubMed
54.
Cheng C, Michaels J, Scheinfeld N. Alitretinoin: a comprehensive review. Expert Opin Investig Drugs. 2008;17:437–43.PubMedCrossRef
55.•
Volf EM, Au SC, Dumont N, et al. A phase 2, open-label investigator-initiated study to evaluate the safety and efficacy of apremilast in subjects with recalcitrant allergic contact or atopic dermatitis. J Drugs Dermatol. 2012;11:341–6. New biologic in a phase II open-label study with several possible dermatologic treatment uses.PubMed
56.•
Gottlieb AB, Matheson RT, Menter A, et al. Efficacy, tolerability, and pharmacodynamics of apremilast in recalcitrant plaque psoriasis: a phase II open-label study. J Drugs Dermatol. 2013;12:888–97. Phase II trial for upcoming biologic that may have application in hand dermatitis.PubMed
57.
Andoh T, Yoshida T, Kuraishi Y. Topical E6005, a novel phosphodiesterase 4 inhibitor, attenuates spontaneous itch-related responses in mice with chronic atopy-like dermatitis. Exp Dermatol. 2014;23:359–61.PubMedCrossRef
58.•
Furue M, Kitahara Y, Akama H, et al. Safety and efficacy of topical E6005, a phosphodiesterase 4 inhibitor, in Japanese adult patients with atopic dermatitis: results of a randomized, vehicle-controlled, multicenter clinical trial. J Dermatol. 2014;41:577–85. Trial with new topical PDE4 inhibitor with potential future uses, including hand dermatitis.PubMedCrossRef
59.
Lillis JV, Guo CS, Lee JJ, et al. Increased IL-23 expression in palmoplantar psoriasis and hyperkeratotic hand dermatitis. Arch Dermatol. 2010;146:918–9.PubMedCrossRef
60.
Griffiths C, Strober B, van de Kerkhof P, et al. Comparison of ustekinumab and etanercept for moderate-to-severe psoriasis. N Engl J Med. 2010;362:118–28.PubMedCrossRef
61.
Fujii Y, Sengoku T. Effects of the Janus kinase inhibitor CP-690550 (tofacitinib) in a rat model of oxazolone-induced chronic dermatitis. Pharmacology. 2013;91:207–13.PubMedCrossRef
Metadata
Title
Hand Dermatitis: an Allergist’s Nightmare
Authors
Lindsey Wold
Jennifer K. Chen
Heather P. Lampel
Publication date
01-11-2014
Publisher
Springer US
Published in
Current Allergy and Asthma Reports / Issue 11/2014
Print ISSN: 1529-7322
Electronic ISSN: 1534-6315
DOI
https://doi.org/10.1007/s11882-014-0474-0

Other articles of this Issue 11/2014

Current Allergy and Asthma Reports 11/2014 Go to the issue

ANAPHYLAXIS AND DRUG ALLERGY (DA KHAN AND M CASTELLS, SECTION EDITORS)

Penicillin and Beta-Lactam Allergy: Epidemiology and Diagnosis

IMMUNOTHERAPY AND IMMUNOMODULATORS (L COX, SECTION EDITOR)

Immune Mechanisms of Sublingual Immunotherapy

Pediatric Allergy and Immunology (JM Portnoy and CE Ciaccio, Section Editors)

Empowering the Child and Caregiver: Yellow Zone Asthma Action Plan

OTITIS (DP SKONER, SECTION EDITOR)

Does the Type of Rhinitis Influence Development of Otitis Media with Effusion in Children?

OTITIS (DP SKONER, SECTION EDITOR)

Role of Obesity in Otitis Media in Children

ASTHMA (WJ CALHOUN AND SP PETERS, SECTION EDITORS)

Critical Review of Bronchial Thermoplasty: Where Should It Fit into Asthma Therapy?